Activity of aurisin A isolated from Neonothopanus nambi against methicillin-resistant Staphylococcus aureus strains
Saudi Pharmaceutical Journal · 2023-05 · 31 (5) · 617-625
DOI: 10.1016/j.jsps.2023.03.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, 2023-05. Verfasst von Getha Krishnasamy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioprospecting Programme, Natural Products Division, Forest Research Institute Malaysia (FRIM), Kepong 52109, Selangor, Malaysia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Mycopharmaceuticals from basidiomycetes represent a promising source of new antimicrobials to overcome the challenges of multidrug-resistant bacteria. Here we report for the first time the in vitro activity of aurisin A, a dimeric sesquiterpenoid isolated from wild bioluminescent basidiomycetes Neonothopanus nambi DSM 24013, against methicillin-resistant Staphylococcus aureus (MRSA). Aurisin A revealed strong anti-MRSA activity with minimum inhibitory concentration 7.81 μg/mL against ATCC 33591 and ATCC 43300 reference strains, and BD 16876 and BD 15358 clinical strains. Activity against the clinical strains is 10- to 40-fold higher than that of the antibiotic fusidic acid. Furthermore, aurisin A proved to be more potent (MIC 3.91 μg/mL) in inhibiting growth of vancomycin-intermediate S. aureus (VISA) ATCC 700699 and displayed a rapid time-dependent bactericidal activity against MRSA (complete killing within 1 h). Additionally, aurisin A and oxacillin combination displayed synergy with notable decrease in the MICs of both compounds against MRSA. Notable synergism was also observed in combinations with linezolid and fusidic acid. Our findings indicate that aurisin A is a promising candidate for developing therapeutic agents against multidrug-resistant S. aureus and warrants further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bioprospecting Programme, Natural Products Division, Forest Research Institute Malaysia (FRIM), Kepong 52109, Selangor, Malaysia.
- Herbal Quality Control Programme, Natural Products Division, Forest Research Institute Malaysia (FRIM), Kepong 52109, Selangor, Malaysia.
- Center for Diagnostic, Therapeutics & Investigative Studies, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
- Center for Toxicology and Health Risk Studies, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
- Department of International Affairs SATREPS Group, Japan Science and Technology Agency (JST), K's Gobancho, 7, Gobancho, Chiyoda-ku, Tokyo 1020076, Japan.
Zitieren
APA
Krishnasamy, G., Azahar, M. S., Rahman, S. S. A., Vallavan, V., Zin, N. M., Latif, M. A., & Hatsu, M. (2023). Activity of aurisin A isolated from Neonothopanus nambi against methicillin-resistant Staphylococcus aureus strains. Saudi Pharmaceutical Journal, 31(5), 617-625. https://doi.org/10.1016/j.jsps.2023.03.002
Vancouver
Krishnasamy G, Azahar MS, Rahman SSA, Vallavan V, Zin NM, Latif MA, et al. Activity of aurisin A isolated from Neonothopanus nambi against methicillin-resistant Staphylococcus aureus strains. Saudi Pharmaceutical Journal. 2023;31(5):617-625. doi:10.1016/j.jsps.2023.03.002
BibTeX
@article{Krishnasamy2023,
author = {Krishnasamy, Getha and Azahar, Muhammad-Syamil and Rahman, Shariffah-Nurhidayah S A and Vallavan, Vimalah and Zin, Noraziah M and Latif, Mazlyzam A and Hatsu, Masahiro},
title = {Activity of aurisin A isolated from Neonothopanus nambi against methicillin-resistant Staphylococcus aureus strains},
journal = {Saudi Pharmaceutical Journal},
year = {2023},
volume = {31},
number = {5},
pages = {617--625},
doi = {10.1016/j.jsps.2023.03.002}
}
EUVIMED